NCT00141349已完成2 期
A Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study to Assess the Time to Onset, Safety, and Toleration of Differing Doses and Combinations of Immediate Release and Modified Release Formulations of UK369,003 in Adult Male Subject With Erectile Dysfunction
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 300
- 试验地点
- 40
- 主要终点
- The time needed to obtain an erection hard enough to attempt sexual intercourse.
研究概览
简要总结
To determine the onset of action, safety and toleration of different formulations and doses of UK-369,003 in patients with erectile dysfunction. Patients should have been previously treated with PDE5 inhibitors and have been responders to the drugs. Duration of treatment is 4 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Erectile dysfunction as defined by DSM-IV. Patients should have been PDE5 inhibitor respondents
排除标准
- •Alpha blockers and Nitrates of any preparation
结局指标
主要结局
The time needed to obtain an erection hard enough to attempt sexual intercourse.
次要结局
- Proportion of responders based on successful erections Based on erections hard enough for sexual intercourse 15, 45 and 60 minutes post dose Proportion of good responders based on successful erections International Index of Erectile Function
研究者
研究点 (40)
Loading locations...
相似试验
已完成
2 期
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile DysfunctionImpotenceNCT00174486Pfizer300
已完成
2 期
Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency VirusHIV InfectionsNCT00643643ViiV Healthcare41
已完成
2 期
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.Prostatic HyperplasiaNCT00457457Pfizer609
已完成
1 期
A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy VolunteersHealthyNCT00997308AstraZeneca97
已完成
1 期
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health AdultsHealthyNCT05351086Pulmatrix Inc.26